Mechanochemical Processing of Thermoplastic Nanocomposites for Regenerative Orthopedic Surgery
US-2018282167-A1 · Oct 4, 2018 · US
US10149926B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10149926-B2 |
| Application number | US-201514873630-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2015 |
| Priority date | Aug 31, 2010 |
| Publication date | Dec 11, 2018 |
| Grant date | Dec 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure pertains to hemostatic compositions comprising a plurality of nonwoven fibers disposed in a rapidly soluble solid matrix and methods of making and using the same. The compositions may also comprise one or more therapeutic agents.
Opening claim text (preview).
What is claimed: 1. A method of sealing a tissue puncture comprising: providing a hemostatic composition comprising: a plurality of nonwoven fibers; a rapidly soluble solid matrix, wherein the fibers are embedded within the rapidly soluble solid matrix such that the space occupied by the fibers is free of voids; and one or more therapeutic agents; inserting the hemostatic composition into a tissue puncture; exposing the hemostatic composition to at least one of a body fluid or saline; liquefying the rapidly soluble solid matrix upon contact with the at least one of a body fluid or saline and releasing the plurality of nonwoven fibers; and allowing the plurality of nonwoven fibers to swell upon contact with the at least one of a body fluid or saline, thereby occluding the tissue puncture. 2. The method of claim 1 , wherein the plurality of nonwoven fibers are greater than about 50 nanometers in diameter and less than about 20 microns in diameter. 3. The method of claim 1 , wherein the plurality of nonwoven fibers comprise a non-cellulosic polysaccharide. 4. The method of claim 1 , wherein the liquefying step releases at least a portion of the one or more therapeutic agents. 5. The method of claim 1 , wherein the rapidly soluble solid matrix comprises a sugar. 6. The method of claim 1 , wherein the rapidly soluble solid matrix consists of a sugar. 7. The method of claim 1 , wherein the rapidly soluble solid matrix comprises water ice. 8. The method of claim 1 , wherein the rapidly soluble solid matrix consists of water ice. 9. The method of claim 1 , wherein the material of the plurality of nonwoven fibers includes crosslinks. 10. The method of claim 1 , wherein the material of the plurality of nonwoven fibers swells upon contact with at least one of a body fluid or saline.
Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)} · CPC title
having a macromolecular matrix · CPC title
Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009) · CPC title
Anti-inflammatory agents, e.g. NSAIDs · CPC title
entirely comprised between the two sides of the opening · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.